Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Cell culture and mouse studies suggest allosteric inhibition of the EED subunit of PRC2 could help treat lymphoma. Screening of small molecule libraries in in vitro activity assays by two independent ...
BCIQ Company Profiles
Abbvie Inc.
Novartis AG
BCIQ Target Profiles
Embryonic ectoderm development (EED)
Polycomb repressive complex 2 (PRC2)